The Health 2030 Genome Center is a multi-institutional hub to promote genomic medicine in Switzerland. The Center is the genomic medicine arm of the Health 2030 initiative for Swiss personalized medicine. The institutions collaborating in the Health 2030 Initiative are the École Polytechnique Fédérale de Lausanne (EPFL), Geneva University Hospitals (HUG), University of Geneva (UNIGE), Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne (UNIL), Bern University Hospital (InselSpital) and University of Bern (UNIBE).
The Genome Center is larger than just a large-scale sequencing facility, it as a hub for genetics and genomics research and clinical applications, it will foster collaborations, increase communication and sharing of ideas and will allow long term development of major initiatives. In addition, we strengthen the impact of the sequencing facility itself since new developments and projects will be discussed and designed in real time through daily interactions of all parties involved. Data analysis pipelines has been and will continuously be developed for clinical and research activities. Clinical-grade and accredited services will be provided for all applications of sequencing.
In a broader genomic vision, we aim at advancing our knowledge about disease pathogenesis, improving human health through preventive, diagnostic and therapeutic approaches, and realizing the social and economic benefits of genomics research.
> To serve as a leading authority in the field of genomics at the national and international levels.
> To be an innovation and technology hub enabling large scale genomic initiatives.
> To serve as a big data management and analysis hub for the genomic needs of researchers and clinicians.
> To advance knowledge about disease and improve human health through genomics-based preventive, diagnostic and therapeutic approaches.
> To enable synergies between Swiss institutions in the area of genomic medicine.
> To promote education of clinicians and other stakeholders in the field of genomics.
Manolis DERMITZAKIS, Director
Jacques FELLAY, Co-Director
Keith HARSHMAN, Chief Operating Officer
Olivier MENZEL, Head of Strategic Partnerships
Elena TORRES, Administrative Coordinator
Ioannis XENARIOS, Chief Analyst
Cédric HOWALD, Data Manager, Data Analyst
Istvan BARTHA, Data Analyst
Jérôme THOMAS, Senior Laboratory Associate
Deborah PENET, Lab Technician
Anthony BLIN, Lab Technician